Surviving Sepsis — Practice Guidelines, Marketing Campaigns, and Eli Lilly von Eichacker, Peter Q, Natanson, Charles, Danner, Robert L

Volltext

Mapping Lilly Reich von Lizondo-Sevilla, Laura, Domingo-Calabuig, Débora

Volltext

Kisunla From Eli Lilly von Holmberg, Monica

Volltext

Lilly A. Koltun: 1951-2021 von Schwartz, Joan M.

Volltext

Ask me anything: Lilly Liu von Durrani, Matin

Volltext

Eli Lilly spends $3.2 billion on Morphic’s oral integrin inhibitor for inflammatory bowel disease von Mullard, Asher

Volltext

Polyphenol characterisation and diverse bioactivities of native Australian lilly pilly () extract von Pachulicz, River J, Yu, Long, Jovcevski, Blagojce, Bulone, Vincent, Pukala, Tara L

Volltext

Bébé Lilly: Decision of the Supreme Court, Commercial Chamber (Cour de cassation, chambre commerciale) 11 January 2017 – Case No. 15-15750 von Intellectual Property Code, Arts. L. 712-6, L. 711-3, L. 711-4, Code of Civil Procedure, Art. 624

Volltext

Lilly Was 32 von Bradley, Burke T

Volltext

Eli Lilly to Acquire Akouos for up to $610M von Philippidis, Alex

Volltext

The Proximal Lilly Collection: Mapping, Exploring and Exploiting Feasible Chemical Space von Nicolaou, Christos A, Watson, Ian A, Hu, Hong, Wang, Jibo

Volltext

Covid-19: Eli Lilly pauses antibody trial for safety reasons von Dyer, Owen

Volltext

Lilly Absorption Modeling Platform: A Tool for Early Absorption Assessment von Stamatis, Stephen D, Rose, John P

Volltext

Lilly Insulin Glargine Versus Lantus® in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5) von Pollom, Robyn K., Ilag, Liza L., Lacaya, Lyndon B., Morwick, Tina M., Ortiz Carrasquillo, Ramón

Volltext

Omvoh From Eli Lilly and Company von Holmberg, Monica

Volltext

Medical writing support was provided by Matt Soulsby, PhD, of Engage Scientific Solutions and was funded by Pfizer and Eli Lilly and Company. CONFLICT OF INTEREST STATEMENT TJS reports clinical research study support from Pfizer, Eli Lilly and Company, Regeneron, Galapagos, Taiwan Liposome Corporation, and Anika Therapeutics and has served as a consultant or on an advisory board for Pfizer, Eli Lilly and Company, Glaxo-Smith Kline, AstraZeneca, Noven, Galapagos, and Merck. FB has received grants von Berenbaum, Francis, Schnitzer, Thomas, Kivitz, Alan, Viktrup, Lars, Johnston, Elizabeth, Yang, Ruoyong, Whalen, Ed, Tive, Leslie, Semel, David

Volltext

Lilly Insulin Glargine Versus Lantus® in Type 2 Diabetes Mellitus Patients: India and East Asia Subpopulation Analyses of the ELEMENT 5 Study von Mohan, Viswanathan, Ahn, Kyu Jeung, Cho, Young Min, Sahay, Rakesh Kumar, Huang, Chien-Ning, Kalra, Sanjay, Chadha, Manoj, Bhattacharya, Indranil, Kim, So Yeon, Spaepen, Erik

Volltext

The History of Flow Chemistry at Eli Lilly and Company von Johnson, Martin D., Braden, Timothy, Calvin, Joel R., Campbell Brewer, Alison, Cole, Kevin P., Frank, Scott, Kerr, Mark, Kjell, Doug, Kopach, Michael E., Martinelli, Joseph R., May, Scott. A., Rincon, Juan, White, Timothy D., Yates, Matthew H.

Volltext

Lilly Nortjé-Meyer’s (En)Gendered New Testament Hermeneutics: Theory, Practice, Engagement von Punt, Jeremy

Volltext

Lilly Lecture 2002: islet transplantation: a brave new world von Ricordi, Camillo

Volltext